1. 2316 Efficacy and toxicity of second-line chemotherapy in patients with advanced oesophageal squamous cell carcinoma progressing after a first line of 5-fluorouracil and platinum-based therapy: An AGEO retrospective multicentric study. (September 2015) Authors: Auzolle, C.; Dubreuil, O.; Pozet, A.; Coriat, R.; Dhooge, M.; Ducreux, M.; Mons, M.; Brieau, B.; Baumgaertner, I.; Gornet, J.M.; Li évre, A.; Locher, C.; Mary, F.; Bonnetain, F.; Landi, B. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S438 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2345 Neoadjuvant docetaxel, cisplatin, and 5-fluorouracil (dcf) compared to standard chemotherapy for resectable gastroesophageal adenocarcinoma. (September 2015) Authors: Kim, S.; Paget-Bailly, S.; Fiteni, F.; Messager, M.; Nguyen, T.; Mathieu, P.; Lamfichekh, N.; Fein, F.; Fratte, S.; Cleau, D.; Calcagno, F.; Lakkis, Z.; Jary, M.; Sakek, N.; Jacquin, M.; Foubert, A.; Bonnetain, F.; Mariette, C.; Borg, C. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S449 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2355 Nab-paclitaxel plus gemcitabine or plus simplified LV5FU2 as first- line therapy in patients with metastatic pancreatic adenocarcinoma. A GERCOR randomized phase II study (AFUGEM). (September 2015) Authors: Bachet, J.B.; Hammel, P.; Desrame, J.; Chibaudel, B.; Debourdeau, P.; Dauba, J.; Lecomte, T.; Seitz, J.F.; Tournigand, C.; Aparicio, T.; Guerin Meyer, V.; Taieb, J.; Volet, J.; Bonnetain, F.; Louvet, C. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S453 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 2376 Impact of the definition of time to event endpoint on randomized clinical trials results in oncology (datecan-2): an analysis of 9 pancreatic cancer trials. (September 2015) Authors: Pam, A.; Vernerey, D.; Baron, B.; Chauffert, B.; Louvet, C.; Wagener, J.; Levi, F.; Hans, S.; Trouilloud, I.; Jan, J.; Van Laethem, J.L.; Taieb, J.; Haustermans, K.; Dahan, L.; Dureux, M.; Lutz, M.; Bellera, C.; Gourgou, S.; Anota, A.; Bonnetain, F. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S462 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 3054 Health-related quality of life in elderly patients with advanced non-small-cell lung cancer comparing carboplatin and weekly paclitaxel doublet chemotherapy with monotherapy in the Phase 3 IFCT-0501 trial. (September 2015) Authors: Fiteni, F.; Anota, A.; Bonnetain, F.; Milleron, B.; Zalcman, G.; Quoix, E.; Westeel, V. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S613 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 746PCOnsensus statement on mandatory measurements in PAncreatic cancer trials for systemic treatment of unresectable disease (COMM-PACT). (18th September 2017) Authors: van Rijssen, L.B.; ter Veer, E.; Besselink, M.G.; Mali, R.M.A.; Berlin, J.; Boeck, S.; Bonnetain, F.; Conroy, T.; Deplanque, G.; Goldstein, D.; Glimelius, B.; Neoptolemos, J.P.; Reni, M.; Scheithauer, W.; van der Meer, J.; Wilmink, J.W.; van der Poel, M.J.; Busch, O.R.; van Oijen, M.G.H.; van Laa... Journal: Annals of oncology Issue: Volume 28(2017)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Idarubicin‐loaded beads for chemoembolisation of hepatocellular carcinoma: results of the IDASPHERE phase I trial. Issue 11 (16th April 2014) Authors: Boulin, M.; Hillon, P.; Cercueil, J. P.; Bonnetain, F.; Dabakuyo, S.; Minello, A.; Jouve, J. L.; Lepage, C.; Bardou, M.; Wendremaire, M.; Guerard, P.; Denys, A.; Grandvuillemin, A.; Chauffert, B.; Bedenne, L.; Guiu, B. Journal: Alimentary pharmacology & therapeutics Issue: Volume 39:Issue 11(2014) Page Start: 1301 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Impact of circulating biomarkers in patients with metastatic colorectal cancer treated with first-line FOLFOX-aflibercept therapy. Results of the GERCOR VELVET Phase II study. (December 2016) Authors: Tijeras-Raballand, A.; De Gramont, A.; Chiron, M.; Bachet, J.B.; André, T.; Auby, D.; Desramé, J.; Baba-Ahmed, N.; Lecaille, C.; Lebrun, V.; Louvet, C.; Tournigand, C.; Benner, S.; Attia, M.; De Gramont, A.; Bonnetain, F.; Chibaudel, B. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Impact of neoadjuvant chemotherapy on survival in breast cancer patients in daily practice: a population‐based study. (5th May 2013) Authors: Dabakuyo, T.S.; Arnaud, A.; Maingon, P.; Causeret, S.; Coudert, B.; Fumoleau, P.; Arnould, L.; Poillot, M.‐L.; Arveux, P.; Crehange, G.; Bonnetain, F. Journal: European journal of cancer care Issue: Volume 22:Number 5(2013:Sep.) Page Start: 638 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials. (July 2018) Authors: Adenis, A.; Alessio, A.; Aouakli, A.; Azzedine, A.; Bedjaoui, A.; Bidault, A.; Blanchi, A.; Botton, A.; Cadier-Lagnes, A.; Fatisse, A.; Gagnaire, A.; Gilbert, A.; Gueye, A.; Hollebecque, A.; Lemaire, A.; Mahamat, A.; Marre, A.; Patenotte, A.; Rotenberg, A.; Roussel, A. Journal: European journal of cancer Issue: Volume 98(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗